Jason S Lewis

This inventor holds 27 USPTO granted patents and 23 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Targeted Imaging Agents. Top assignees: Memorial Sloan Kettering Cancer Center, Sloan-Kettering Institute for Cancer Research, Cornell University. Active years: 2017-2026.

USPTO Granted Patents = 27 (Patent Applications = 23)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 7 (Patent Applications = 22)

Average Co-Inventor Count = 6.1

ph-index = 5

Forward Citations = 72(Granted Patents)

Location History:

New York City, NY (US) (2020)
New York, NY (US) (2017 - 2024)

Company Filing History:

18 out of 618

Memorial Sloan Kettering Cancer Center

patents

8 out of 519

Sloan-Kettering Institute for Cancer Research

Adjuvance Technologies, Inc.

patents

5. 2 out of 336

The City University of New York

patents

6. 1 out of 11

Tri-Institutional Therapeutics Discovery Institute

patents

7. 1 out of 897

University of Missouri

patents

8. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2017-2026

Loading Chart...

Areas of Expertise:

Radioligands

PET Imaging

Theranostic Agents

PSMA Positive Cancers

Multimodal Nanoparticles

Antibody-Drug Conjugates

Fluorescent Silica

HSP90 Inhibitors

Prostate Cancer

Diagnostics

Therapeutics

Saponin Analogues

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12734258 - Radioligands for pretargeted PET imaging and methods of their therapeutic use (2026-09-15),

2. 12685791 - Free PSA antibodies as diagnostics, prognostics and therapeutics for prostate cancer (2026-07-21),

3. 12616759 - USES OF LABELED HSP90 INHIBITORS (2026-05-05),

4. 12582728 - Theranostic agents for PSMA positive cancers (2026-03-24),

5. 12551583 - RADIOLABELED LIGANDS FOR TARGETED PET/SPECT IMAGING AND METHODS OF THEIR USE (2026-02-17),

6. 12486323 - ANTI-L1-CAM ANTIBODIES AND USES THEREOF (2025-12-02),

7. 12441789 - DLL3-targeting antibodies and uses thereof (2025-10-14),

8. 12187755 - Minimal saponin analogues, synthesis and use thereof (2025-01-07),

9. 12161734 - Multimodal silica-based nanoparticles (2024-12-10),

10. 12037355 - Triterpene saponin analogues (2024-07-16),

11. 11607465 - Uses of labeled HSP90 inhibitors (2023-03-21),

12. 11597764 - Anti-L1-CAM antibodies and uses thereof (2023-03-07),

13. 11446400 - Free PSA antibodies as diagnostics, prognostics and therapeutics for prostate cancer (2022-09-20),

14. 11419955 - Multimodal silica-based nanoparticles (2022-08-23),

15. 11274116 - Minimal saponin analogues, synthesis and use thereof (2022-03-15),

Title: The Inventive Journey of Jason Lewis

Introduction: Jason Lewis, a talented inventor hailing from New York, NY, has made significant contributions to the world of innovation through his creative mind and dedication to problem-solving.

Latest Patents: Jason Lewis holds several patents in various fields, including a groundbreaking design for a sustainable energy system and a unique method for enhancing communication technologies.

Career Highlights: With a background in engineering and a passion for creating solutions, Jason Lewis has successfully brought several of his inventions to market, improving efficiency and sustainability in different industries.

Collaborations: Throughout his career, Jason Lewis has collaborated with leading research institutions and technology companies to further develop his inventions and bring them to a wider audience, showcasing his ability to work effectively in multidisciplinary teams.

Conclusion: Jason Lewis stands as a shining example of an innovative thinker and inventor, whose dedication to pushing the boundaries of technology continues to inspire others in the field of innovation.